APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amisulpride

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amisulpride Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchAmisulpride Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Amisulpride Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Amisulpride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amisulpride Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Amisulpride Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Amisulpride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amisulpride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amisulpride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amisulpride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amisulpride market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amisulpride market include Sanofi, Qilu Pharma and Vexxa Lifescience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amisulpride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amisulpride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amisulpride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amisulpride market size, projected growth trends, production technologies, key applications, and end-use industries.

Amisulpride Segment by Company

Sanofi

Qilu Pharma

Vexxa Lifescience

Amisulpride Segment by Type

50mg/Tablet

400mg/Tablet

200mg/Tablet

Amisulpride Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Amisulpride Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Amisulpride status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Amisulpride market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amisulpride significant trends, drivers, influence factors in global and regions.

6. To analyze Amisulpride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amisulpride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amisulpride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amisulpride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amisulpride market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amisulpride industry.

Chapter 3: Detailed analysis of Amisulpride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Amisulpride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Amisulpride in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amisulpride Industry Trends Table 2. Amisulpride Industry Drivers Table 3. Amisulpride Industry Opportunities and Challenges Table 4. Amisulpride Industry Restraints Table 5. Global Amisulpride Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amisulpride Revenue Share by Company (2021-2026) Table 7. Global Amisulpride Sales Volume by Company (kg) & (2021-2026) Table 8. Global Amisulpride Sales Volume Share by Company (2021-2026) Table 9. Global Amisulpride Average Price (US$/kg) of Company (2021-2026) Table 10. Global Amisulpride Company Ranking, (2024-2026) & (USD Million) Table 11. Global Amisulpride Key Company Manufacturing Base & Headquarters Table 12. Global Amisulpride Company, Product Type & Application Table 13. Global Amisulpride Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Amisulpride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50mg/Tablet Table 18. Significant Companies of 400mg/Tablet Table 19. Significant Companies of 200mg/Tablet Table 20. Global Amisulpride Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Amisulpride Sales Volume by Type (2021-2026) & (kg) Table 22. Global Amisulpride Sales Volume by Type (2027-2032) & (kg) Table 23. Global Amisulpride Sales Volume Share by Type (2021-2026) Table 24. Global Amisulpride Sales Volume Share by Type (2027-2032) Table 25. Global Amisulpride Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Amisulpride Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Amisulpride Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Amisulpride Sales Value Share by Type (2021-2026) Table 29. Global Amisulpride Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Hospital Pharmacies Table 33. Global Amisulpride Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Amisulpride Sales Volume by Application (2021-2026) & (kg) Table 35. Global Amisulpride Sales Volume by Application (2027-2032) & (kg) Table 36. Global Amisulpride Sales Volume Share by Application (2021-2026) Table 37. Global Amisulpride Sales Volume Share by Application (2027-2032) Table 38. Global Amisulpride Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Amisulpride Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Amisulpride Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Amisulpride Sales Value Share by Application (2021-2026) Table 42. Global Amisulpride Sales Value Share by Application (2027-2032) Table 43. Global Amisulpride Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Amisulpride Sales by Region (2021-2026) & (kg) Table 45. Global Amisulpride Sales Market Share by Region (2021-2026) Table 46. Global Amisulpride Sales by Region (2027-2032) & (kg) Table 47. Global Amisulpride Sales Market Share by Region (2027-2032) Table 48. Global Amisulpride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Amisulpride Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Amisulpride Sales Value Share by Region (2021-2026) Table 51. Global Amisulpride Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Amisulpride Sales Value Share by Region (2027-2032) Table 53. Global Amisulpride Market Average Price (US$/kg) by Region (2021-2026) Table 54. Global Amisulpride Market Average Price (US$/kg) by Region (2027-2032) Table 55. Global Amisulpride Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Amisulpride Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Amisulpride Sales by Country (2021-2026) & (kg) Table 58. Global Amisulpride Sales Market Share by Country (2021-2026) Table 59. Global Amisulpride Sales by Country (2027-2032) & (kg) Table 60. Global Amisulpride Sales Market Share by Country (2027-2032) Table 61. Global Amisulpride Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Amisulpride Sales Value Market Share by Country (2021-2026) Table 63. Global Amisulpride Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Amisulpride Sales Value Market Share by Country (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Amisulpride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 68. Sanofi Amisulpride Product Portfolio Table 69. Sanofi Recent Development Table 70. Qilu Pharma Company Information Table 71. Qilu Pharma Business Overview Table 72. Qilu Pharma Amisulpride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 73. Qilu Pharma Amisulpride Product Portfolio Table 74. Qilu Pharma Recent Development Table 75. Vexxa Lifescience Company Information Table 76. Vexxa Lifescience Business Overview Table 77. Vexxa Lifescience Amisulpride Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 78. Vexxa Lifescience Amisulpride Product Portfolio Table 79. Vexxa Lifescience Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Amisulpride Distributors List Table 83. Amisulpride Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Amisulpride Product Image Figure 2. Global Amisulpride Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amisulpride Sales Value (2021-2032) & (US$ Million) Figure 4. Global Amisulpride Sales (2021-2032) & (kg) Figure 5. Global Amisulpride Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Amisulpride Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50mg/Tablet Image Figure 10. 400mg/Tablet Image Figure 11. 200mg/Tablet Image Figure 12. Global Amisulpride Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Amisulpride Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Amisulpride Sales Volume Share by Type (2021-2032) Figure 15. Global Amisulpride Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Amisulpride Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Amisulpride Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Global Amisulpride Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Amisulpride Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Amisulpride Sales Volume Share by Application (2021-2032) Figure 24. Global Amisulpride Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Amisulpride Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Amisulpride Sales Value Share by Application (2021-2032) Figure 27. Global Amisulpride Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Amisulpride Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Amisulpride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Amisulpride Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Amisulpride Sales Value (2021-2032) & (US$ Million) Figure 32. North America Amisulpride Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Amisulpride Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Amisulpride Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Amisulpride Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Amisulpride Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Amisulpride Sales Value (2021-2032) & (US$ Million) Figure 38. South America Amisulpride Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Amisulpride Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Amisulpride Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Amisulpride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Amisulpride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Amisulpride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Amisulpride Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Amisulpride Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg/Tablet
  • 400mg/Tablet
  • 200mg/Tablet
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Sanofi
  • Qilu Pharma
  • Vexxa Lifescience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amisulpride Sales Value (2021-2032)
  4. 1.2.2 Global Amisulpride Sales Volume (2021-2032)
  5. 1.2.3 Global Amisulpride Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Amisulpride Market Dynamics
  1. 2.1 Amisulpride Industry Trends
  2. 2.2 Amisulpride Industry Drivers
  3. 2.3 Amisulpride Industry Opportunities and Challenges
  4. 2.4 Amisulpride Industry Restraints
3 Amisulpride Market by Company
  1. 3.1 Global Amisulpride Company Revenue Ranking in 2025
  2. 3.2 Global Amisulpride Revenue by Company (2021-2026)
  3. 3.3 Global Amisulpride Sales Volume by Company (2021-2026)
  4. 3.4 Global Amisulpride Average Price by Company (2021-2026)
  5. 3.5 Global Amisulpride Company Ranking (2024-2026)
  6. 3.6 Global Amisulpride Company Manufacturing Base and Headquarters
  7. 3.7 Global Amisulpride Company Product Type and Application
  8. 3.8 Global Amisulpride Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Amisulpride Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Amisulpride Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Amisulpride Market by Type
  1. 4.1 Amisulpride Type Introduction
  2. 4.1.1 50mg/Tablet
  3. 4.1.2 400mg/Tablet
  4. 4.1.3 200mg/Tablet
  5. 4.2 Global Amisulpride Sales Volume by Type
  6. 4.2.1 Global Amisulpride Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Amisulpride Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Amisulpride Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Amisulpride Sales Value by Type
  10. 4.3.1 Global Amisulpride Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Amisulpride Sales Value by Type (2021-2032)
  12. 4.3.3 Global Amisulpride Sales Value Share by Type (2021-2032)
5 Amisulpride Market by Application
  1. 5.1 Amisulpride Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Amisulpride Sales Volume by Application
  6. 5.2.1 Global Amisulpride Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amisulpride Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Amisulpride Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Amisulpride Sales Value by Application
  10. 5.3.1 Global Amisulpride Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Amisulpride Sales Value by Application (2021-2032)
  12. 5.3.3 Global Amisulpride Sales Value Share by Application (2021-2032)
6 Amisulpride Regional Sales and Value Analysis
  1. 6.1 Global Amisulpride Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amisulpride Sales by Region (2021-2032)
  3. 6.2.1 Global Amisulpride Sales by Region: 2021-2026
  4. 6.2.2 Global Amisulpride Sales by Region (2027-2032)
  5. 6.3 Global Amisulpride Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Amisulpride Sales Value by Region (2021-2032)
  7. 6.4.1 Global Amisulpride Sales Value by Region: 2021-2026
  8. 6.4.2 Global Amisulpride Sales Value by Region (2027-2032)
  9. 6.5 Global Amisulpride Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Amisulpride Sales Value (2021-2032)
  12. 6.6.2 North America Amisulpride Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Amisulpride Sales Value (2021-2032)
  15. 6.7.2 Europe Amisulpride Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Amisulpride Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Amisulpride Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Amisulpride Sales Value (2021-2032)
  21. 6.9.2 South America Amisulpride Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Amisulpride Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Amisulpride Sales Value Share by Country, 2025 VS 2032
7 Amisulpride Country-level Sales and Value Analysis
  1. 7.1 Global Amisulpride Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amisulpride Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Amisulpride Sales by Country (2021-2032)
  4. 7.3.1 Global Amisulpride Sales by Country (2021-2026)
  5. 7.3.2 Global Amisulpride Sales by Country (2027-2032)
  6. 7.4 Global Amisulpride Sales Value by Country (2021-2032)
  7. 7.4.1 Global Amisulpride Sales Value by Country (2021-2026)
  8. 7.4.2 Global Amisulpride Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Amisulpride Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Amisulpride Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Amisulpride Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Amisulpride Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Amisulpride Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Amisulpride Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Amisulpride Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Amisulpride Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Amisulpride Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Amisulpride Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Amisulpride Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Amisulpride Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Amisulpride Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Amisulpride Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Amisulpride Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Amisulpride Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Amisulpride Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Amisulpride Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Amisulpride Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Amisulpride Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Amisulpride Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Amisulpride Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Amisulpride Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Amisulpride Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Amisulpride Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Amisulpride Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Amisulpride Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Amisulpride Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Amisulpride Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Amisulpride Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Amisulpride Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Amisulpride Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Amisulpride Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Amisulpride Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Amisulpride Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Amisulpride Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Amisulpride Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Amisulpride Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Amisulpride Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Amisulpride Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Amisulpride Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Amisulpride Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Amisulpride Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Amisulpride Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Amisulpride Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Amisulpride Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Amisulpride Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Amisulpride Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Amisulpride Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Amisulpride Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Amisulpride Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Amisulpride Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Amisulpride Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Amisulpride Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Amisulpride Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Amisulpride Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Amisulpride Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Amisulpride Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Amisulpride Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Amisulpride Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Amisulpride Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Amisulpride Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Amisulpride Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Amisulpride Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Amisulpride Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Amisulpride Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Amisulpride Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Amisulpride Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Amisulpride Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Amisulpride Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Amisulpride Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Amisulpride Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Amisulpride Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Amisulpride Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Amisulpride Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Amisulpride Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Amisulpride Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Amisulpride Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Amisulpride Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Amisulpride Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Amisulpride Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Amisulpride Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Amisulpride Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Amisulpride Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Amisulpride Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Amisulpride Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Qilu Pharma
  8. 8.2.1 Qilu Pharma Company Information
  9. 8.2.2 Qilu Pharma Business Overview
  10. 8.2.3 Qilu Pharma Amisulpride Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Pharma Amisulpride Product Portfolio
  12. 8.2.5 Qilu Pharma Recent Developments
  13. 8.3 Vexxa Lifescience
  14. 8.3.1 Vexxa Lifescience Company Information
  15. 8.3.2 Vexxa Lifescience Business Overview
  16. 8.3.3 Vexxa Lifescience Amisulpride Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vexxa Lifescience Amisulpride Product Portfolio
  18. 8.3.5 Vexxa Lifescience Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amisulpride Value Chain Analysis
  2. 9.1.1 Amisulpride Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amisulpride Sales Mode & Process
  6. 9.2 Amisulpride Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amisulpride Distributors
  9. 9.2.3 Amisulpride Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst